Document Detail

Network approaches to drug discovery.
MedLine Citation:
PMID:  23140510     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Advances in genomics technologies are providing a very large amount of data on genome-wide gene expression profiles, protein molecules and their interactions with other macromolecules and metabolites. Molecular interaction networks provide a useful way to capture this complex data and comprehend it. Networks are beginning to be used in drug discovery, in many steps of the modern discovery pipeline, with large-scale molecular networks being particularly useful for the understanding of the molecular basis of the disease.
AREAS COVERED: The authors discuss network approaches used for drug target discovery and lead identification in the drug discovery pipeline. By reconstructing networks of targets, drugs and drug candidates as well as gene expression profiles under normal and disease conditions, the paper illustrates how it is possible to find relationships between different diseases, find biomarkers, explore drug repurposing and study emergence of drug resistance. Furthermore, the authors also look at networks which address particular important aspects such as off-target effects, combination-targets, mechanism of drug action and drug safety.
EXPERT OPINION: The network approach represents another paradigm shift in drug discovery science. A network approach provides a fresh perspective of understanding important proteins in the context of their cellular environments, providing a rational basis for deriving useful strategies in drug design. Besides drug target identification and inferring mechanism of action, networks enable us to address new ideas that could prove to be extremely useful for new drug discovery, such as drug repositioning, drug synergy, polypharmacology and personalized medicine.
Nagasuma Chandra; Jyothi Padiadpu
Publication Detail:
Type:  Journal Article; Review     Date:  2012-11-10
Journal Detail:
Title:  Expert opinion on drug discovery     Volume:  8     ISSN:  1746-045X     ISO Abbreviation:  Expert Opin Drug Discov     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2012-12-24     Completed Date:  2013-10-17     Revised Date:  2013-11-06    
Medline Journal Info:
Nlm Unique ID:  101295755     Medline TA:  Expert Opin Drug Discov     Country:  England    
Other Details:
Languages:  eng     Pagination:  7-20     Citation Subset:  IM    
Indian Institute of Science, Department of Biochemistry, Bangalore - 560012 , India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Drug Discovery / methods*,  trends
Genomics / methods,  trends
Information Services* / trends
Models, Biological*
Protein Interaction Maps / genetics

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intra-genomic GC heterogeneity in sauropsids: evolutionary insights from cDNA mapping and GC(3) prof...
Next Document:  Malignant mesothelioma of the tunica vaginalis testis: a malignancy associated with recurrent epidid...